Get the Stockscreener App
5.45
3.54%
-0.20
Pre-market:
5.45
Glucotrack Inc stock is traded at $5.45, with a volume of 235.08K.
It is down -3.54% in the last 24 hours and up +5,643% over the past month.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
See More
Previous Close:
$5.65
Open:
$5.65
24h Volume:
235.08K
Relative Volume:
0.06
Market Cap:
$3.48M
Revenue:
-
Net Income/Loss:
$-8.74M
P/E Ratio:
-2.6585
EPS:
-2.05
Net Cash Flow:
$-8.25M
1W Performance:
-11.09%
1M Performance:
+5,643%
6M Performance:
+244.94%
1Y Performance:
-83.58%
1-Day Range:
$5.29
$6.14
1-Week Range:
$5.29
$6.14
52-Week Range:
$0.0927
$62.60
Glucotrack Inc Stock (GCTK) Company Profile
Name
Glucotrack Inc
Sector
Industry
Phone
972 (8) 675-7878
Address
301 RT 17 NORTH, RUTHERFORD
Compare GCTK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
5.45 | 3.48M | 0 | -8.74M | -8.25M | -2.05 |
|
ISRG
Intuitive Surgical Inc
|
512.23 | 188.99B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
178.31 | 50.05B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.95 | 43.06B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
252.01 | 37.62B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
221.05 | 15.84B | 2.90B | 467.20M | 306.90M | 6.37 |
Glucotrack Inc Stock (GCTK) Latest News
Why GlucoTrack Inc. stock attracts strong analyst attentionFree Smart Investment Opportunities - Newser
How GlucoTrack Inc. stock performs during market volatilityFree Stock Market Analysis Courses - Newser
GlucoTrack (NASDAQ:GCTK) Stock Price Down 1.2% – Here’s What Happened - Defense World
What makes GlucoTrack Inc. stock price move sharplyFree Access to Investment Community - Newser
Implantable glucose monitor competitor emerges with early data - MedTech Dive
GlucoTrack Completes Major Warrant Repurchase - TipRanks
Glucotrack, Inc. Successfully Repurchases Over 90% of Series A Warrants as Part of Capital Formation Strategy - Nasdaq
Glucotrack Announces Repurchase of Series A Warrants - Yahoo Finance
U.S. Stock Movers Today: ULY, NNNN, QS, GCTK, RITR - Markets.com
GlucoTrack Innovation’s Surprise Move: What’s Next? - timothysykes.com
GlucoTrack Inc (NASDAQ: GCTK) – An Analysis Is What You Need - Stocksregister
GlucoTrack (NASDAQ:GCTK) Shares Up 2.6% – What’s Next? - Defense World
Glucotrack announces 1:60 reverse stock split - Investing.com
GlucoTrack Implements Reverse Stock Split - TipRanks
Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements - mx.advfn.com
Glucotrack announces 1-for-60 reverse stock split effective June 16 By Investing.com - Investing.com South Africa
Glucotrack announces 1-for-60 reverse stock split effective June 16 - Investing.com Nigeria
GlucoTrack Announces 1-for-60 Reverse Stock Split - TipRanks
Glucotrack Implements Major 1-for-60 Reverse Split: What This Means for Your Investment - Stock Titan
Glucotrack’s Innovative Approach to Diabetes Management Sets New Standards - citybuzz -
Rebuilding Trust: How Glucotrack Is Establishing A New Standard In Diabetes Management - Nasdaq
Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions - mx.advfn.com
GlucoTrack to Present at ADA Scientific Sessions - TipRanks
Revolutionary Diabetes Tech: Glucotrack's 3-Year Implantable Monitor Eliminates Daily Finger Pricks - Stock Titan
Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions - The Manila Times
GCTK stock plunges to 52-week low, hits $0.13 By Investing.com - Investing.com South Africa
GCTK stock plunges to 52-week low, hits $0.13 - Investing.com India
Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives - The Globe and Mail
Glucotrack appoints new board member with diabetes tech expertise By Investing.com - Investing.com South Africa
Glucotrack appoints new board member with diabetes tech expertise - Investing.com
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD - The Manila Times
GlucoTrack (NASDAQ:GCTK) Trading Down 0.2% – Time to Sell? - Defense World
GlucoTrack Approves Key Proposals at Annual Meeting - TipRanks
GCTK stock plunges to 52-week low, touches $0.13 - Investing.com Australia
GCTK stock plunges to 52-week low, touches $0.13 By Investing.com - Investing.com Nigeria
GlucoTrack Establishes Patient Advisory Board for CBGM - TipRanks
Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development - The Manila Times
Glucotrack, Inc. Forms Patient Advisory Board to Enhance Development of Continuous Blood Glucose Monitor - Nasdaq
Groundbreaking 3-Year Implantable Glucose Monitor Gets Patient-Led Development at Glucotrack - Stock Titan
Glucotrack Reports Q1 2025 Financial Results and Progress - TipRanks
Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times
Innovative Continuous Blood Glucose Monitor Shows Promise in First Human Trial - citybuzz -
GlucoTrack Reports Q1 2025 Financial Results and Progress - TipRanks
Glucotrack Inc Stock (GCTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):